International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 129-136, March 2007

A fully liquid diphtheria–tetanus–five component acellular pertussis–inactivated poliomyelitis–Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants

  • Tzou Yien Lin

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Ying-Hsiang Wang

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Luan-Yin Chang

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Yhu-Chering Huang

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Hsiu-Tsun Kao

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Pen-Yi Lin

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Hsiao-Kuo Lu

      Affiliations

    • Chang-Gung Children's Hospital, Taoyuan, Taiwan
  • ,
  • Pascale Chavand

      Affiliations

    • Medical Affairs International, Sanofi Pasteur International, 2, avenue Pont Pasteur, 69007 Lyon, France
  • ,
  • Esteban Ortiz

      Affiliations

    • Medical Affairs International, Sanofi Pasteur International, 2, avenue Pont Pasteur, 69007 Lyon, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 4 3737 7258; fax: +33 4 3737 7171.

Received 3 June 2005; received in revised form 6 October 2005; accepted 25 October 2005.

Corresponding Editor: Jonathan Cohen, Brighton, UK

Summary 

Objective

To assess the immunogenicity of a fully liquid diphtheria–tetanus–five component acellular pertussis–inactivated poliomyelitis–Haemophilus influenzae type b (DTaP–IPV–Hib) conjugate vaccine compared to DTaP–IPV and lyophilized Hib conjugate vaccines given simultaneously at separate sites as a three-dose primary vaccination in Taiwanese infants.

Methods

Two hundred infants were randomized to receive either DTaP–IPV–Hib or DTaP–IPV plus Hib vaccine at 2, 4, and 6 months of age. Both combined vaccines contained the same five pertussis antigens: pertussis toxoid (PT), filamentous hemagglutinin (FHA), pertactin (PRN), fimbriae 2 and 3 (FIM 2&3). Antibody concentrations were measured before the first and after the third dose. Reactogenicity was evaluated from parental reports. All subjects received hepatitis B vaccine at 0, 1, and 6 months of age following the national vaccination schedule of Taiwan.

Results

The immunogenicity after the third dose was high for each vaccine antigen in both groups, and the vaccines had low reactogenicity. Statistical analysis showed no differences in the immune responses to the fully liquid DTaP–IPV–Hib vaccine compared with those to the DTaP–IPV plus Hib control vaccines, notably the anti-PRP (polyribose ribitol phosphate capsular polysaccharide) response, with 97–99% of infants having concentrations ≥1.0μg/mL. Approximately 95% of all infants developed seroprotective levels of anti-hepatitis B surface antigen (HBs) antibodies (≥10mIU/mL).

Conclusions

Both combination vaccines had similar high immunogenicity for each antigen, and both were well tolerated. Thus, inclusion of a Haemophilus influenzae type b conjugate vaccine in the combination did not result in clinically significant decrease in the PRP response or increase reactogenicity. The fully liquid pentavalent vaccine has the advantages of not requiring reconstitution and of administration as a single injection.

Keywords: Acellular pertussis, Fully liquid combination vaccine, Haemophilus influenzae type b, Pentavalent vaccine

 

 Presented at the 11th International Congress on Infectious Diseases, Cancun, Mexico, March 5–7, 2004 as “Immunogenicity and safety of a fully liquid DTaP–IPV–Hib vaccine given as a three-dose primary vaccination in Taiwanese infants”.

PII: S1201-9712(06)00057-9

doi:10.1016/j.ijid.2005.10.014

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 129-136, March 2007